Vittorio Studiale, Medical Oncology resident at Pisan hospital-university, shared on X:
“CtDNA in early CRC
> different MRD assays, need for validation
> FN/FP results still a relevant issue
> many ongoing clinical trials all clearly put into context by Jeanne Tie.“.
Source: Vittorio Studiale/X